GlassScriptPhysician profile
Catherine M Baker
NPI 1376561936
$1,671.85
in general payments reported to CMS, 2019-2025
13 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $645 · 2023: $324 · 2024: $70.28 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioptics, INC. | $508.68 | 2020 | |
| Lunit Americas, INC. | $323.51 | 2023 | |
| Hologic Sales and Service, LLC | $185.69 | 2025 | Magtrace |
| Dilon Technologies, INC. | $174.17 | 2025 | Hemoblast Bellows |
| Musculoskeletal Transplant Foundation INC. | $146.17 | 2025 | |
| Focal Therapeutics, INC. | $136.07 | 2020 | |
| Integra Lifesciences Corporation | $40.88 | 2024 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Janssen Biotech, INC. | $29.40 | 2024 | Rybrevant |
| Solventum Corporation | $28.81 | 2025 | 3m Duraprep Surgical, Prevena Restor Bellaform, Prevena |
| Novartis Pharmaceuticals Corporation | $28.80 | 2025 | |
| Mentor Worldwide LLC | $28.49 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Biocon Biologics INC | $23.54 | 2025 | Ogivri |
| Bayer Healthcare Pharmaceuticals INC. | $17.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.